We have experienced this with vaccines. We saw that there was work to be done.
Ms. Furlong and Mr. Asselin, I don't have a lot of time left, but I would like you to explain something to me. What do you think could be done in the short, medium or long term to allow for a little more robust and efficient operation?
I don't know if you were familiar with the networks of centres of excellence program, which was a federal program that had apparently had some success in translational research. I've heard a lot about it. What government actions could be taken in the short, medium or long term to achieve better linkage between research and commercialization?